GO
Loading...

BRIEF-Cell Therapeutics jumps in premarket after opaxiotm gets orphan drug designation

NEW YORK, Oct 2 (Reuters) - Cell Therapeutics Inc :

* Jumps 23.3 percent to $2.75 in premarket after opaxiotm gets orphan drug designation from U.S. Food and Drug Administration for malignant brain cancer

((Wall Street Newsdesk Telephone: +1 646-223-6110))

Symbol
Price
 
Change
%Change
CTIC
---